Sign Up to like & get
recommendations!
0
Published in 2020 at "Pain management"
DOI: 10.2217/pmt-2019-0052
Abstract: The US FDA has encouraged the development of abuse-deterrent formulations (ADFs) of opioid analgesics as one component in a comprehensive effort to combat prescription opioid abuse. Guidance issued by the FDA outlines three types of…
read more here.
Keywords:
guide clinicians;
analgesics guide;
abuse deterrent;
opioid analgesics ... See more keywords